| Name | THR-β agonist 2 |
|---|
| Description | THR-β agonist 2 is a potent agonist of THR-β. THR-β agonist 2 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021121210A1, compound 3)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C18H8Cl2N6O4 |
|---|---|
| Molecular Weight | 443.20 |